New intermediate-stage subclassification for patients with hepatocellular carcinoma treated with transarterial chemoembolization-Reference-Cited by-同舟云学术

New intermediate-stage subclassification for patients with hepatocellular carcinoma treated with transarterial chemoembolization

Published:2017-06-26 Issue:12 Volume:37 Page:1861-1868
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Kim Jin Hyoung¹^ORCID,Shim Ju Hyun²^ORCID,Lee Han Chu²,Sung Kyu-Bo¹,Ko Heung-Kyu¹,Ko Gi-young¹,Gwon Dong Il¹,Kim Jong Woo¹,Lim Young-Suk²,Park Seong Ho¹

Affiliation:

1. Department of Radiology and Research Institute of Radiology; Asan Liver Center; Asan Medical Center; University of Ulsan College of Medicine; Songpa-Gu Seoul Korea

2. Department of Gastroenterology; Asan Liver Center; Asan Medical Center; University of Ulsan College of Medicine; Songpa-Gu Seoul Korea

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13487/fullpdf

Reference20 articles.

1. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?;Lencioni;Oncologist,2010

2. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system;Han;World J Gastroenterol,2015

3. Current strategy for staging and treatment: the BCLC update and future prospects;Forner;Semin Liver Dis,2010

4. Prospective validation of the Barcelona Clinic Liver Cancer staging system;Cillo;J Hepatol,2006

5. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;European Association For The Study Of The Liver;J Hepatol,2012

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TACE plus lenvatinib and tislelizumab for intermediate-stage hepatocellular carcinoma beyond up-to-11 criteria: a multicenter cohort study;Frontiers in Immunology;2024-07-26

2. Standards for the Transarterial Chemoembolization Procedure as the Hepatocellular Carcinoma Treatment: Literature Review. Part 1;Journal of oncology: diagnostic radiology and radiotherapy;2024-07-04

3. Evolution of Systemic Treatment for Hepatocellular Carcinoma: Changing Treatment Strategies and Concepts;Cancers;2024-06-28

4. Prediction of Efficacy for Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma with Hepatobiliary-Phase Gadolinium Ethoxybenzyl-Diethylenetriaminepentaacetic Acid MRI;Cancers;2024-06-19

5. Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinoma;Scientific Reports;2024-05-13